Aligos Therapeutics (ALGS) Shares Issued (2021 - 2024)
Historic Shares Issued for Aligos Therapeutics (ALGS) over the last 4 years, with Q4 2024 value amounting to $139000.0.
- Aligos Therapeutics' Shares Issued rose 5444.44% to $139000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $229000.0, marking a year-over-year decrease of 5662.88%. This contributed to the annual value of $436000.0 for FY2024, which is 2087.11% down from last year.
- Aligos Therapeutics' Shares Issued amounted to $139000.0 in Q4 2024, which was up 5444.44% from $90000.0 recorded in Q4 2023.
- Aligos Therapeutics' Shares Issued's 5-year high stood at $78.3 million during Q3 2021, with a 5-year trough of $10000.0 in Q1 2022.
- In the last 4 years, Aligos Therapeutics' Shares Issued had a median value of $98500.0 in 2021 and averaged $7.9 million.
- As far as peak fluctuations go, Aligos Therapeutics' Shares Issued plummeted by 8958.33% in 2022, and later skyrocketed by 33366.34% in 2023.
- Over the past 4 years, Aligos Therapeutics' Shares Issued (Quarter) stood at $78.3 million in 2021, then plummeted by 99.88% to $94000.0 in 2022, then decreased by 4.26% to $90000.0 in 2023, then soared by 54.44% to $139000.0 in 2024.
- Its last three reported values are $139000.0 in Q4 2024, $90000.0 for Q4 2023, and $438000.0 during Q2 2023.